• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by Director Singer David B

    2/18/26 8:56:41 AM ET
    $CCCX
    Blank Checks
    Finance
    Get the next $CCCX alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    SINGER DAVID B

    (Last) (First) (Middle)
    C/O INFLEQTION, INC.
    1315 WEST CENTURY DRIVE, SUITE 150

    (Street)
    LOUISVILLE CO 80027

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Churchill Capital Corp X/Cayman [ INFQ ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    02/13/2026
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Stock Option (Right to Buy) $0.9 02/13/2026 A(1) 34,740 (2) 06/05/2034 Common Stock 34,740 (3) 34,740 D(4)
    Stock Option (Right to Buy) $13.22 02/13/2026 A 29,950 (5) 02/12/2036 Common Stock 29,950 $0 29,950 D(4)
    Explanation of Responses:
    1. Received pursuant to the Agreement and Plan of Merger and Reorganization, dated as of September 8, 2025, by and among Churchill Capital Corp X, a Delaware corporation now known as Infleqtion, Inc. ("Acquiror"), AH Merger Sub I, Inc., a direct, wholly-owned Subsidiary of Acquiror ("Merger Sub I"), AH Merger Sub II, LLC, a direct, wholly-owned Subsidiary of Acquiror ("Merger Sub II" and together with Merger Sub I, "Merger Subs") and ColdQuanta, Inc. (the "Company") pursuant to which (a) Merger Sub I was merged with and into the Company, and the Company continued as the surviving corporation and immediately thereafter, (b) the Company merged with and into Merger Sub II, and Merger Sub II became the surviving company and continued in existence as a wholly-owned subsidiary of Acquiror (collectively, the "Mergers"). In connection with the Mergers, Acquiror changed its name to Infleqtion, Inc. (the "Issuer").
    2. Fully vested.
    3. Pursuant to the Mergers, the legacy stock options of the Company were automatically converted into the right to receive stock options of the Issuer with the same terms and conditions.
    4. The economic benefit of the director compensation provided in respect of the Reporting Person's board service passes to Maverick Ventures Investment Fund, L.P. through a management fee offset. The Reporting Person disclaims, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, beneficial ownership of these securities, except to the extent of his pecuniary interest therein.
    5. 1/3rd of the shares underlying the option shall vest on February 17, 2027, and 1/36th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.
    /s/ Jason D. Hall, Attorney-in-Fact 02/18/2026
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $CCCX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CCCX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CCCX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Infleqtion and Churchill Capital Corp X Complete Business Combination

    Infleqtion to become the first publicly listed neutral-atom quantum technology company and will begin trading on the NYSE under ticker symbol "INFQ" on February 17, 2026 Infleqtion, Inc. ("Infleqtion"), a global leader in quantum sensing and quantum computing powered by neutral-atom technology, today announced the completion of its previously announced business combination with Churchill Capital Corp X (NASDAQ:CCCX) ("Churchill X"), a special purpose acquisition company. Churchill X, whose shares of common stock, warrants and units were listed on The Nasdaq Stock Market LLC ("Nasdaq") has delisted from Nasdaq, and shares of common stock and warrants of the post‑combination company, Infl

    2/13/26 12:09:00 PM ET
    $CCCX
    Blank Checks
    Finance

    Churchill Capital Corp X Shareholders Approve Business Combination with Infleqtion

    Nearly 100% of trust cash retained ahead of closing Over $550 million of gross proceeds to be delivered to Infleqtion Transaction expected to close February 13, 2026 Churchill Capital Corp X ("Churchill X") (NASDAQ:CCCX), a publicly traded special purpose acquisition company, today announced that its shareholders have approved the previously announced business combination with Infleqtion, Inc. ("Infleqtion"), a global leader in quantum sensing and quantum computing powered by neutral-atom technology. At a special meeting held today, the business combination and all related proposals were approved with overwhelming support from Churchill X shareholders, with over 90% of votes cast at

    2/12/26 4:00:00 PM ET
    $CCCX
    Blank Checks
    Finance

    Infleqtion Founder & Chief Science Officer Dr. Dana Anderson Elected to the National Academy of Engineering

    Membership comes in recognition of Dr. Anderson's contributions to optical quantum engineering of ultracold atoms Infleqtion, a global leader in quantum sensing and quantum computing, develops atom-based quantum technology for commercial and government applications. Infleqtion is proud to announce the induction of Dr. Dana Anderson into the National Academy of Engineering (NAE) for contributions to optical quantum engineering of ultracold atoms. Infleqtion recently announced plans to go public through a merger with Churchill Capital Corp X (NASDAQ:CCCX). "I am honored to be a member of this year's National Academy of Engineering class," said Dr. Dana Anderson, Founder and Chief Science

    2/12/26 2:30:00 PM ET
    $CCCX
    Blank Checks
    Finance

    $CCCX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Maverick Capital Ltd claimed ownership of 19,941,924 shares (SEC Form 3)

    3 - Churchill Capital Corp X/Cayman (0002007825) (Issuer)

    2/18/26 8:09:05 PM ET
    $CCCX
    Blank Checks
    Finance

    SEC Form 4 filed by Director Singer David B

    4 - Churchill Capital Corp X/Cayman (0002007825) (Issuer)

    2/18/26 8:56:41 AM ET
    $CCCX
    Blank Checks
    Finance

    SEC Form 4 filed by Director Meyerriecks Dawn Clawson

    4 - Churchill Capital Corp X/Cayman (0002007825) (Issuer)

    2/18/26 8:55:22 AM ET
    $CCCX
    Blank Checks
    Finance

    $CCCX
    SEC Filings

    View All

    SEC Form SCHEDULE 13D filed by Churchill Capital Corp X

    SCHEDULE 13D - Churchill Capital Corp X/Cayman (0002007825) (Subject)

    2/18/26 8:09:47 PM ET
    $CCCX
    Blank Checks
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by Churchill Capital Corp X

    SCHEDULE 13G/A - Churchill Capital Corp X/Cayman (0002007825) (Subject)

    2/17/26 4:47:39 PM ET
    $CCCX
    Blank Checks
    Finance

    Amendment: SEC Form SCHEDULE 13D/A filed by Churchill Capital Corp X

    SCHEDULE 13D/A - Churchill Capital Corp X/Cayman (0002007825) (Subject)

    2/17/26 4:30:03 PM ET
    $CCCX
    Blank Checks
    Finance